| 1 |
Therapeutic drug monitoring of common antipsychotics |
|
| | Patteet, L. and Morrens, M. and Maudens, K.E. and Niemegeers, P. and Sabbe, B. and Neels, H. | | | Therapeutic Drug Monitoring. 2012; 34(6): 629-651 | | | [Pubmed] [Google Scholar] | | | 2 |
Therapeutic Drug Monitoring of Common Antipsychotics |
|
| | Lisbeth Patteet,Manuel Morrens,Kristof E. Maudens,Peter Niemegeers,Bernard Sabbe,Hugo Neels | | | Therapeutic Drug Monitoring. 2012; 34(6): 629 | | | [Pubmed] [Google Scholar] [DOI] | | | 3 |
Overdose of atypical antipsychotics: clinical presentation, mechanisms of toxicity and management |
|
| | Levine M, Ruha AM. | | | CNS Drugs. 2012 Jul 1;26(7):601-11. 2012; 26(7): 601-611 | | | [Pubmed] [Google Scholar] [DOI] | | | 4 |
Atypical antipsychotics: trends in analysis and sample preparation of various biological samples |
|
| | Domniki Fragou, Spyridoula Dotsika, Parthena Sarafidou, Victoria Samanidou, Samuel Njau, Leda Kovatsi | | | Bioanalysis. 2012; 4(8): 961-980 | | | [Pubmed] [Google Scholar] [DOI] | | | 5 |
Asenapina — nowy atypowy lek przeciwpsychotyczny Asenapine — a new atypical antipsychotic |
|
| | A Wysokiński, I Kłoszewska | | | Psychiatry. 2012; 9(1): 27-35 | | | [HTML Full text] [Google Scholar] | |
|
